Jefferies Initiates Coverage On Edwards Lifesciences with Buy Rating, Announces Price Target of $110
Jefferies analyst Matthew Taylor initiates coverage on Edwards Lifesciences (NYSE:EW) with a Buy rating and announces Price Target of $110.